Date of Award

Fall 2024

Abstract

Continuous Glucose Monitors (CGMs) are an essential tool for managing diabetes in the outpatient setting, helping individuals achieve glucose goals. However, CGMs are not currently FDA-approved for use in the hospital setting. Despite this limitation, many individuals continue using their personal CGM during hospitalization or begin using them prior to discharge if the care team believes the technology will support glucose management during and after leaving the hospital.

This project aimed to evaluate whether individuals using personal CGMs during hospitalization experienced less hypoglycemia and whether reviewing CGM data could improve provider confidence in insulin dosing. While initiating CGM use during hospitalization posed challenges, no hypoglycemia was observed among individuals using CGMs. Additionally, higher mean glucose levels were linked to lower provider confidence in achieving glucose targets, though this was not directly influenced by CGM use alone. Further research is needed to identify and overcome barriers to CGM initiation, assess the cost-benefit balance, and examine the effects of inpatient CGM use on readmission rates and overall clinical outcomes.

Document Type

Clinical Doctorate

First Advisor

Jane Seley

College or School

CHHS

Department or Program

Nursing

Degree Name

Other

Share

COinS